Products Categories
CAS No.: | 5053-08-7 |
---|---|
Name: | Fenspiride hydrochloride |
Molecular Structure: | |
Formula: | C15H20 N2 O2 . Cl H |
Molecular Weight: | 296.797 |
Synonyms: | 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,8-(2-phenylethyl)-, monohydrochloride (9CI);1-Oxa-3,8-diazaspiro[4.5]decan-2-one, 8-phenethyl-, monohydrochloride (8CI);8-Phenethyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride; Decaspir;Decaspiride; Erespal; Fenspiride hydrochloride; Fluiden; JP 428; NAT 333; NDR5998A; Pneumorel; Tegencia; Viarespan |
Density: | 1.19g/cm3 |
Melting Point: | 235-238oC (dec.) |
Boiling Point: | 474.3°Cat760mmHg |
Flash Point: | 240.6°C |
Hazard Symbols: | Xn |
Risk Codes: | 20/21/22 |
Safety: | Poison by ingestion, intraperitoneal, and intravenous routes. A bronchodilator and antiadrenergic agent. When heated to decomposition it emits very toxic fumes of NOx and HCl. |
PSA: | 41.57000 |
LogP: | 2.87220 |
What can I do for you?
Get Best Price
DECASPIRIDE HYDROCHLORIDE(5053-08-7) appears the white power.
And DECASPIRIDE HYDROCHLORIDE(5053-08-7) has some properties listed in the following.
Molecular Formula:C15H20N2O2 .ClH
Molecular Weight:296.83
Density:1.19g/cm3
Boiling Point:474.3°C at760mmHg
Flash Point:240.6°C
Properties: A solid. Mp: 232–233°C (decomp).
1. | orl-rat LD50:437 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 19 (1969),1263. | ||
2. | ivn-rat LD50:122 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 193 (1971),111. | ||
3. | orl-mus LD50:250 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 193 (1971),111. | ||
4. | ipr-mus LD50:230 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 19 (1969),1263. | ||
5. | ivn-mus LD50:106 mg/kg | MEIEDD Merck Index. 10 (1983),575. | ||
6. | ivn-dog LD50:74 mg/kg | BCFAAI Bollettino Chimico Farmaceutico. 117 (1978),343. | ||
7. | orl-gpg LD50:260 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 193 (1971),111. | ||
8. | ipr-gpg LD50:210 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 193 (1971),111. |